James Fox, Director at GenMark Diagnostics, Inc. (GNMK), bought 23,810 shares at $4.20 ($100K) on 2012-06-26, disclosed to the SEC on 2012-06-28.
Open-market purchase of $100k GNMK by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| BOTA | BUY | 2015-06-15 | $142K | — | Filing → |
| BOTA | BUY | 2015-06-11 | $139K | — | Filing → |